Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Vion and Yale amend key license agreements

Aug. 26, 1997

R.P. Scherer sells ophthalmic delivery system to Pharmacia & Upjohn

Aug. 26, 1997

Molecular Dynamics and Amersham announce microarray technology agreement with Chiron

Aug. 26, 1997

Alexion reports novel retroviral vectors for gene therapy

Aug. 22, 1997

Gene interaction studies without blood tests

Aug. 22, 1997

ISO 9001 given to Senetek for drug delivery system

Aug. 22, 1997

Millennium reports discovery of new MAD-related proteins

Aug. 21, 1997

Oxis granted patent application allowance for ergothioneine analogs

Aug. 20, 1997

Three patents issued for ProLease and Medisorb

Aug. 19, 1997

Drug discovery agreement forged by Procept, Abbott

Aug. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...